Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis

Journal of Controlled Release

Volumn 159, Issue 2, 2012, Pages 189-196

  Rafi, Md ^a   Cabral, H ^b   Kano, M R ^a,b   Mi, P ^b   Iwata, C ^a   Yashiro, M ^c   Hirakawa, K ^c   Miyazono, K ^a,b   Nishiyama, N ^a,b   Kataoka, K ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Drug delivery; Gastric cancer; Lymph node metastasis; Polymeric micelles

Indexed keywords

ANTICANCER DRUG; DRUG CARRIER; DRUG-TARGETING; GASTRIC CANCERS; GASTRIC TUMORS; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHATIC METASTASIS; METASTATIC TUMORS; NANOCARRIERS; ORTHOTOPIC; OXALIPLATIN; POLYMERIC MICELLE; SOLID TUMORS; TUMOR GROWTH;

BODY FLUIDS; CHEMOTHERAPY; DISEASES; DRUG DELIVERY; ENZYME INHIBITION; MICELLES; PATHOLOGY; PLATINUM; PLATINUM COMPOUNDS; TUMORS;

POLYMERS;

NANOCARRIER; OXALIPLATIN; PLATINUM 1,2 DIAMINOCYCLOHEXANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR GROWTH;

ADENOCARCINOMA, SCIRRHOUS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; HUMANS; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICELLES; ORGANOPLATINUM COMPOUNDS; POLYETHYLENE GLYCOLS; POLYGLUTAMIC ACID; POLYMERS; STOMACH NEOPLASMS; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84861099393     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.01.038     Document Type: Article

References (39)

1. R. Duncan The dawning era of polymer therapeutics Nat. Rev. Drug Discov. 2 2003 347 360 (Pubitemid 37361705)
2. M.E. Davis, Z. Chen, and D. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discov. 7 2008 771 782
3. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 47 2001 113 131 (Pubitemid 32209236)
4. N. Nishiyama, and K. Kataoka Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery Pharmacol. Ther. 112 2006 630 648 (Pubitemid 44592613)
5. H. Cabral, N. Nishiyama, and K. Kataoka Supramolecular nanodevices: from design validation to theranostic nanomedicine, Acc. Chem. Res. 44 2011 999 1008
6. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs Cancer Res. 46 1986 6387 6392 (Pubitemid 17221789)
7. J.J. Gottlieb, K. Washenik, A. Chachoua, and A. Friedman-Kien Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin Lancet 350 1997 1363 1364 (Pubitemid 28036906)
8. W.J. Gradishar, S. Tjulandin, N. Davidson, H. Shaw, N. Desai, P. Bhar, M. Hawkins, and J. O'Shaughnessy Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J. Clin. Oncol. 23 2005 7794 7803 (Pubitemid 46657376)
9. M.R. Kano, Y. Bae, C. Iwata, Y. Morishita, M. Yashiro, M. Oka, T. Fujii, A. Komuro, K. Kiyono, M. Kaminishi, K. Hirakawa, Y. Ouchi, N. Nishiyama, K. Kataoka, and K. Miyazono Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling Proc. Natl. Acad. Sci. U. S. A. 104 2007 3460 3465 (Pubitemid 46364181)
10. M.R. Kano, Y. Komuta, C. Iwata, M. Oka, Y.T. Shirai, Y. Morishita, Y. Ouchi, K. Kataoka, and K. Miyanozo Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-β receptor inhibitor on extravasation of nanoparticles from neovasculature Cancer Sci. 100 2009 173 180
11. K.D. Crew, and A.I. Neugut Epidemiology of gastric cancer World J. Gastroenterol. 12 2006 354 362 (Pubitemid 43329250)
12. E. Otsuji, Y. Kuriu, K. Okamoto, T. Ochiai, D. Ichikawa, A. Hagiwara, and H. Yamagishi Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach Am. J. Surg. 188 2004 327 332 (Pubitemid 39278295)
13. Japanese Gastric Cancer A Japanese classification of gastric carcinoma - 2nd English Edition Gastric Cancer 1 1998 10 24
14. Y. Hippo, M. Yashiro, M. Ishii, H. Taniguchi, S. Tsutumi, K. Hirakawa, T. Kosama, and H. Aburatani Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes Cancer Res. 61 2001 889 895 (Pubitemid 32174397)
15. Y. Maehara, Y. Emi, H. Baba, Y. Adachi, K. Akazawa, Y. Ichiyoshi, and K. Sugimachi Recurrences and related characteristics of gastric cancer Br. J. Cancer 74 1996 975 979 (Pubitemid 26319336)
16. A. Hagiwara, T. Takahashi, K. Sawai, C. Sakakura, M. Shirasu, M. Ohgaki, T. Imanishi, J. Yamasaki, Y. Takemoto, and N. Kageyama Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer - a pilot study Anticancer Drugs 8 1997 666 670 (Pubitemid 27404723)
17. C. Oussoren, and G. Storm Liposomes to target the lymphatics by subcutaneous administration Adv. Drug Deliv. Rev. 50 2001 143 156 (Pubitemid 32727280)
18. P. Hirnle Targeted introduction of substances into the lymph nodes for endolymphatic therapy Stanley P.L. Leong, Cancer metastasis and the lymphovascular system: basis for rational therapy 2007 Springer 101
19. K. Yamagata, K. Kumagai, K. Shimizu, K. Masuo, Y. Nishida, and A. Yasui Gastrointestinal cancer metastasis and lymphogenous spread: viewpoint of animal models of lymphatic obstruction Jpn. J. Clin. Oncol. 28 1998 104 106 (Pubitemid 128526029)
20. Y. Matsumura, T. Hamaguchi, T. Ura, K. Muro, Y. Yamada, Y. Shimada, K. Shirao, T. Okusaka, H. Ueno, M. Ikeda, and N. Watanabe Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin Br. J. Cancer 91 2004 1775 1781 (Pubitemid 39664964)
21. T. Hamaguchi, K. Kato, H. Yasui, C. Morizane, M. Ikeda, H. Ueno, K. Muro, Y. Yamada, T. Okusuka, K. Shirao, Y. Shimada, H. Nakahama, and Y. Matsumura A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation Br. J. Cancer 97 2007 170 176 (Pubitemid 47057476)
22. Y. Matsumura, and K. Kataoka Preclinical and clinical studies of anticancer agent-incorporating polymer micelles Cancer Sci. 100 2009 572 579
23. Y. Matsumura Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect Adv. Drug Deliv. Rev. 63 2010 184 192
24. R. Plummer, R.H. Wilson, H. Calvert, A.V. Boddy, M. Griffin, J. Sludden, M.J. Tilby, M. Eatock, D.G. Pearson, C.J. Ottley, Y. Matsumura, K. Kataoka, and T. Nishiya A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours Br. J. Cancer 104 2011 593 598
25. H. Cabral, N. Nishiyama, S. Okazaki, H. Koyama, and K. Kataoka Preparation and biological properties of dichloro(1,2-diaminocyclohexane) platinum (II) (DACHPt)-loaded polymeric micelles J. Control. Release 101 2005 223 232 (Pubitemid 39600985)
26. H. Cabral, N. Nishiyama, and K. Kataoka Optimization of (1,2-diamino-cyclohexane) platinum(II)-loaded polymeric micelles directed to improved tumour targeting and enhanced antitumour activity J. Control. Release 121 2007 146 155 (Pubitemid 47212536)
27. S. Kaida, H. Cabral, M. Kumagai, A. Kishimura, Y. Terada, M. Sekino, I. Aoki, N. Nishiyama, T. Tani, and K. Kataoka Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model Cancer Res. 70 2010 7031 7041
28. M. Murakami, H. Cabral, Y. Matsumoto, S. Wu, M.R. Kano, T. Yamori, N. Nishiyama, and K. Kataoka Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting Sci. Transl. Med. 3 2011 64ra2
29. H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami, M. Kimura, Y. Terada, M.R. Kano, K. Miyazono, M. Uesaka, N. Nishiyama, and K. Kataoka Accumulation of sub-100nm polymeric micelles in poorly permeable tumours depends on size Nat. Nanotech. 6 2011 815 823
30. T. Fujihara, T. Sawada, K. Hirakawa, Y.S. Chung, M. Yashiro, T. Inoue, and M. Sowa Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis Clin. Exp. Metastasis 16 1998 389 398 (Pubitemid 28255534)
31. M. Yashiro, and K. Hirakawa Cancer-stromal interactions in scirrhous gastric carcinoma Cancer Microenviron. 3 2010 127 135
32. K. Shibuya, J. Shirakawa, T. Kameyama, S. Honda, S. Tahara Hanaoka, A. Miyamoto, M. Onodera, T. Sumida, H. Nakauchi, H. Miyoshi, and A. Shibuya CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation J. Exp. Med. 198 2003 1829 1839 (Pubitemid 38032116)
33. C. Iwata, M.R. Kano, A. Komuro, M. Oka, K. Kiyono, E. Johansson, Y. Morishita, M. Yashiro, K. Hirakawa, M. Kaminishi, and K. Miyazono Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis Cancer Res. 67 2007 10181 10189 (Pubitemid 350070790)
34. D.E. Jenkins, Y. Oei, Y.S. Hornig, S.F. Yu, J. Dusich, T. Purchio, and P.R. Contag Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis Clin. Exp. Metastasis. 20 2003 733 744 (Pubitemid 38019275)
35. M.S. Karpeh, L. Leon, D. Klimstra, and M.F. Brennan Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients Ann. Surg. 232 2000 362 371
36. C.Y. Chen CY, C.W. Wu, S.S. Lo, M.C. Hsieh, W.Y. Lui, and K.H. Shen Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma Hepatogastroenterology 49 2002 874 877
37. C. Oussoren, and G. Storm Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol) Pharm. Res. 14 1997 1479 1484 (Pubitemid 27481083)
38. G. Luo, X. Yu, C. Jin, F. Yang, D. Fu, J. Long, J. Xu, C. Zhan, and W. Lu LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors Int. J. Pharm. 385 2010 150 156
39. M.G. Harisinghani, J. Barentsz, P.F. Hahn, W.M. Deserno, S. Tabatabaei, C.H. van de Kaa, J. de la Rosette, and R. Weissleder Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N. Engl. J. Med. 348 2003 2491 2499 (Pubitemid 36706536)